foscarnet has been researched along with prednisolone in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (45.45) | 29.6817 |
2010's | 6 (54.55) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Battmer, K; Dammann, E; Eder, M; Ganser, A; Hambach, L; Heil, G; Hertenstein, B; Stucki, A | 1 |
Goldstein, D; Kelly, J; Lloyd, A; Rawlinson, W; Senanayake, S; Waliuzzaman, Z | 1 |
Chan, KC; Chan, PK; Cockram, CS; Lee, N; Lun, SW; Ma, C; Tang, JW; Wong, BC; Wong, CK; Wu, J | 1 |
Kobayashi, R; Matsumoto, Y; Nasu, T; Suzuki, D; Takanashi, K; Uetake, K | 1 |
Bidier, M; Enk, A; Hadaschik, E; Hartmann, M; Pushkarevskaya, A | 1 |
Quan, SC; Skondra, D | 1 |
2 review(s) available for foscarnet and prednisolone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Bone Marrow Transplantation; Combined Modality Therapy; Cyclosporine; Cystitis; Cytarabine; Cytomegalovirus Infections; DNA, Neoplasm; Female; Foscarnet; Ganciclovir; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Histocompatibility; Humans; Hydroxyurea; Immunosuppressive Agents; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Mitoxantrone; Neoplasms, Second Primary; Prednisolone; Prostaglandins; Remission Induction; Topotecan; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation | 2001 |
9 other study(ies) available for foscarnet and prednisolone
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multicentric Castleman's disease treated with antivirals and immunosuppressants.
Topics: Aged; Anti-Inflammatory Agents; Antineoplastic Agents, Alkylating; Antiviral Agents; Castleman Disease; Chlorambucil; Cidofovir; Cytosine; Drug Therapy, Combination; Foscarnet; Herpesvirus 8, Human; Humans; Immunosuppressive Agents; Male; Organophosphonates; Organophosphorus Compounds; Prednisolone; Sarcoma, Kaposi; Treatment Outcome | 2003 |
Cytokine responses in a severe case of glandular fever treated successfully with foscarnet combined with prednisolone and intravenous immunoglobulin.
Topics: Adolescent; Anti-Inflammatory Agents; Antibodies, Viral; Antiviral Agents; Cytokines; DNA, Viral; Drug Therapy, Combination; Foscarnet; Herpesvirus 4, Human; Humans; Immunoglobulin G; Immunoglobulin M; Immunoglobulins, Intravenous; Immunologic Factors; Infectious Mononucleosis; Male; Prednisolone; Viral Load | 2009 |
Retinitis from cytomegalovirus during maintenance treatment for acute lymphoblastic leukemia.
Topics: Antimetabolites, Antineoplastic; Antiviral Agents; Child; Cytomegalovirus Retinitis; Drug Therapy, Combination; Foscarnet; Humans; Immunocompromised Host; Immunosuppressive Agents; L-Lactate Dehydrogenase; Lymphohistiocytosis, Hemophagocytic; Male; Methotrexate; Methylprednisolone; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Recurrence; Retinal Detachment; Vincristine | 2012 |
Viral reactivation imitates relapse of pemphigus vulgaris in an immunosuppressed patient.
Topics: Autoantibodies; Combined Modality Therapy; Cytomegalovirus; Debridement; Desmoglein 1; Desmoglein 3; Diagnosis, Differential; Drug Therapy, Combination; Female; Follow-Up Studies; Foscarnet; Herpesvirus 1, Human; Herpesvirus 2, Human; Herpesvirus 3, Human; Humans; Immunosuppression Therapy; Middle Aged; Mycophenolic Acid; Pemphigus; Prednisolone; Recurrence; Virus Activation | 2017 |
Case Report: Varicella-zoster Encephalitis with Acute Retinal Necrosis and Oculomotor Nerve Palsy.
Topics: Aged; Antiviral Agents; Aqueous Humor; Cerebrospinal Fluid; Drug Therapy, Combination; Encephalitis, Varicella Zoster; Eye Infections, Viral; Foscarnet; Glucocorticoids; Herpes Zoster Ophthalmicus; Herpesvirus 3, Human; Humans; Infusions, Intravenous; Intravitreal Injections; Male; Oculomotor Nerve Diseases; Polymerase Chain Reaction; Prednisolone; Quality of Life; Retinal Necrosis Syndrome, Acute; Valacyclovir; Visual Acuity | 2019 |